BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
AEterna Zentaris (AEZS) To Present At Upcoming Rodman & Renshaw Annual Global Investment Conference In New York 9/3/2014 4:18:09 PM
AEterna Zentaris (AEZS) Reports Second Quarter 2014 Financial And Operating Results 8/8/2014 8:17:47 AM
AEterna Zentaris (AEZS) To Present At Upcoming Canaccord Genuity 34th Annual Global Growth Conference In Boston 8/6/2014 8:57:54 AM
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014 6:28:36 AM
AEterna Zentaris (AEZS) To Restructure R&D, Will Slash About A Third Of Its Workforce By End Of 2014 6/10/2014 9:50:00 AM
AEterna Zentaris (AEZS): Poster Presented At American Society of Clinical Oncology Meeting On The Design Of The Current Zoptec Phase 3 Trial In Endometrial Cancer 6/2/2014 7:10:44 AM
AEterna Zentaris (AEZS): Poster To Be Presented On The Design Of Current ZoptEC Phase 3 Trial In Endometrial Cancer With Zoptarelin Doxorubicin At American Society of Clinical Oncology 5/22/2014 6:59:36 AM
AEterna Zentaris (AEZS) Announces At the Market Issuance Program 5/12/2014 8:23:57 AM
AEterna Zentaris (AEZS) Announces Board Of Directors Leadership Change And Election Of Directors At Annual Meeting Of Shareholders 5/12/2014 6:46:25 AM
AEterna Zentaris (AEZS) Reports First Quarter 2014 Financial And Operating Results 5/9/2014 6:56:04 AM
12345678910...